Korean Circ J.  2017 Nov;47(6):868-876. 10.4070/kcj.2016.0403.

Initial Report of the Korean Organ Transplant Registry (KOTRY): Heart Transplantation

Affiliations
  • 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • 2Department of Internal Medicine, Sungkyunkwan University College of Medicine, Seoul, Korea.
  • 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • 4Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. jjkim@amc.seoul.kr

Abstract

BACKGROUND AND OBJECTIVES
The Korean Organ Transplant Registry (KOTRY), which was the first national transplant registry in Korea, was founded by the Korean Society for Transplantation and the Korean Center for Disease Control in 2014. Here, we present the initial report of the Korean Heart Transplant Registry.
METHODS
A total of 183 heart transplantation (HTPL) patients performed at 4 nationally representative hospitals were collected from April 2014 to December 2015. We analyzed donor and recipient characteristics, treatment patterns, and immediate post-transplantation outcomes.
RESULTS
One hundred and eighty-three patients were enrolled. The mean age of the patients was 50.5±13.5 years. The mean age of the male recipients was 4 years greater than that of the female recipients (51.7±13.3 years vs. 47.9±13.7 years, p < 0.050). The mean age of donors was more than 12 years younger than that of heart recipients (37.6±10.1 years). Dilated cardiomyopathy was the predominant cause (69%) of heart failure in recipients, followed by ischemic heart diseases (14%) and valvular heart disease (4%). Rejection episodes were most frequent in the 1-6-month period after transplantation (48%), and rarely required intensive treatment. Infection episodes were most frequent <1 month after transplantation (66%) and bacterial and viral infections were equally reported. The 1-year survival rate was 91.6% and most mortality cases occurred during the perioperative period within 1 month after transplantation.
CONCLUSION
With the establishment of the KOTRY in 2014, it is now possible to present nationwide epidemiological data for HTPL in Korea for the first time. The KOTRY is the first national HTPL registry in Korea, and will continue until 2023.

Keyword

Heart transplantation; Heart failure; Registries

MeSH Terms

Cardiomyopathy, Dilated
Centers for Disease Control and Prevention (U.S.)
Female
Heart Failure
Heart Transplantation*
Heart Valve Diseases
Heart*
Humans
Korea
Male
Mortality
Myocardial Ischemia
Perioperative Period
Registries
Survival Rate
Tissue Donors
Transplants*

Figure

  • Figure 1 Age distribution of heart recipients. (A) Male, (B) Female.

  • Figure 2 Causes of HF. CMP = cardiomyopathy; HF = heart failure; IHD = ischemic heart disease.

  • Figure 3 Rejection after transplantation and treatment. (A) 1 month, (B) 6 months, (C) 12 months.


Cited by  5 articles

Increased Risk with Older Donor Age and More Frequent Pre-transplant ECMO: the Second Official KOTRY Report
Jong-Chan Youn, In-Cheol Kim, Nam-Hee Park, Hyungseop Kim
Korean Circ J. 2019;49(8):738-741.    doi: 10.4070/kcj.2019.0117.

The Korean Organ Transplant Registry (KOTRY): Second Official Adult Heart Transplant Report
Darae Kim, Jin-Oh Choi, Jaewon Oh, Hyun Jai Cho, Sung-Ho Jung, Hae-Young Lee, Seok-Min Kang, Jae-Joong Kim, Eun-Seok Jeon
Korean Circ J. 2019;49(8):724-737.    doi: 10.4070/kcj.2018.0392.

A Successful Pregnancy and Delivery after Heart Transplantation: The First Case Report from Korea
Hyo-In Choi, Jung Ae Hong, Min-Seok Kim, Sang Eun Lee, Sung-Ho Jung, Hye-Sung Won, Jae-Joong Kim
J Korean Soc Transplant. 2018;32(3):69-73.    doi: 10.4285/jkstn.2018.32.3.69.

Acute Myocardial Infarction due to Cardiac Allograft Vasculopathy: An Autopsy Report
Moon-Young Kim, Jang Han Kim, Min Jee Park, Soong Deok Lee
Korean J Leg Med. 2018;42(3):92-97.    doi: 10.7580/kjlm.2018.42.3.92.

Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Definition and Diagnosis
Jae Yeong Cho, Dong-Hyuk Cho, Jong-Chan Youn, Darae Kim, Sang Min Park, Mi-Hyang Jung, Junho Hyun, Jimi Choi, Hyun-Jai Cho, Seong-Mi Park, Jin-Oh Choi, Wook-Jin Chung, Byung-Su Yoo, Seok-Min Kang,
Korean Circ J. 2023;53(4):195-216.    doi: 10.4070/kcj.2023.0046.


Reference

1. Lee SE, Cho HJ, Lee HY, et al. A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry. Eur J Heart Fail. 2014; 16:700–708.
2. Choi DJ, Han S, Jeon ES, et al. Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the Korean heart failure registry. Korean Circ J. 2011; 41:363–371.
3. Lund LH, Edwards LB, Dipchand AI, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant. 2016; 35:1158–1169.
4. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37:2129–2200.
5. Jung SH, Kim JJ, Choo SJ, Yun TJ, Chung CH, Lee JW. Long-term mortality in adult orthotopic heart transplant recipients. J Korean Med Sci. 2011; 26:599–603.
6. Cha MJ, Lee HY, Cho HJ, Hwang HY, Kim KB, Oh BH. Under-utilization of donor hearts in the initial era of the heart transplant program in Korea- review of 13 years’ experience from the Korea national registry. Circ J. 2013; 77:2056–2063.
7. Ahn C, Koo TY, Jeong JC, et al. Initial report of the Korean Organ Transplant Registry: the first report of national kidney transplantation data. Transplant Proc. 2014; 46:425–430.
8. Mehra MR, Crespo-Leiro MG, Dipchand A, et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant. 2010; 29:717–727.
9. Youn JC, Seo SM, Lee HS, et al. Trends in hospitalized acute myocardial infarction patients with heart failure in Korea at 1998 and 2008. J Korean Med Sci. 2014; 29:544–549.
10. Yeom SY, Hwang HY, Oh SJ, Cho HJ, Lee HY, Kim KB. Heart transplantation in the elderly patients: midterm results. Korean J Thorac Cardiovasc Surg. 2013; 46:111–116.
11. Lim JH, Hwang HY, Yeom SY, Cho HJ, Lee HY, Kim KB. Percutaneous extracorporeal membrane oxygenation for graft dysfunction after heart transplantation. Korean J Thorac Cardiovasc Surg. 2014; 47:100–105.
12. Shin HS, Cho HJ, Jeon ES, et al. The impact of hepatitis B on heart transplantation: 19 years of national experience in Korea. Ann Transplant. 2014; 19:182–187.
13. Lee JM, Lee SA, Cho HJ, et al. Impact of perioperative renal dysfunction in heart transplantation: combined heart and kidney transplantation could help to reduce postoperative mortality. Ann Transplant. 2013; 18:533–549.
14. Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Official Adult Heart Transplant Report--2014; focus theme: retransplantation. J Heart Lung Transplant. 2014; 33:996–1008.
15. Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report--2013; focus theme: age. J Heart Lung Transplant. 2013; 32:951–964.
16. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th Official Adult Heart Transplant Report--2012. J Heart Lung Transplant. 2012; 31:1052–1064.
17. Lim JY, Jung SH, Kim MS, et al. Cardiac allograft vasculopathy after heart transplantation: is it really ominous? Clin Transplant. 2017; 31:e12883.
18. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med. 2003; 349:847–858.
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr